Italia markets closed

ILMN Jun 2024 60.000 put

OPR - OPR Prezzo differito. Valuta in USD.
Aggiungi a watchlist
0,15000,0000 (0,00%)
Alla chiusura: 09:46AM EDT
Schermo intero
Chiusura precedente0,1500
Aperto0,1500
Denaro0,0000
Lettera4,4000
Prezzo d'esercizio60,00
Scadenza2024-06-21
Min-Max giorno0,1500 - 0,1500
Contratto - Min-MaxN/D
Volume11
Open Interest61
  • GlobeNewswire

    Myriad Genetics and Illumina Achieve Milestones in Strategic Partnership to Support Biopharma Clinical Trials

    Myriad can conduct prospective clinical trials using Illumina’s TruSight Oncology Comprehensive Investigational Use Only testSALT LAKE CITY, Sept. 19, 2023 (GLOBE NEWSWIRE) -- Myriad Genetics, Inc. (NASDAQ: MYGN), a leader in genetic testing and precision medicine, today announced two key milestones in its strategic partnership with Illumina Inc. (NASDAQ: ILMN), a global leader in DNA sequencing and array-based technologies, to advance and support clinical research for gene-based, targeted thera